Literature DB >> 8804993

Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster.

K Kamino1, A Yoshiiwa, Y Nishiwaki, K Nagano, H Yamamoto, T Kobayashi, Y Nonomura, H Yoneda, T Sakai, M Imagawa, T Miki, T Ogihara.   

Abstract

Senile dementia of Alzheimer's type (SDAT) is characterized by progressive deficits of multiple cognitive functions in elderly more than 65 years of age. The APOE-epsilon 4 allele has been shown to be a risk factor for SDAT. To investigate the genetic interactions between SDAT and the APOE/APOC1/APOC2 gene cluster located at 19q13.2, we genotyped these genes in patients with SDAT and nondemented controls. Although allelic associations were found between the APOC1 locus and SDAT (p = 0.0022) as well as between the APOE locus and SDAT (p < 0.0001), no associations were detected between the APOC2 locus and SDAT. And the association between the APOE and APOC1 locus in SDAT was statistically more significant than that in controls (p < 0.001). Estimation of the haplotype frequencies indicated that the association between the APOE/APOC1 haplotype and SDAT was more significant than linkage disequilibrium between the APOE and APOC1 locus (p < 0.01). These results suggest that genetic interaction between the APOE and APOC1 gene could modify a risk factor of APOE-epsilon 4 for SDAT. The APOE/APOC1 locus was estimated to be responsible for 54.8% of SDAT in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804993     DOI: 10.1159/000213820

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  8 in total

1.  The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.

Authors:  S E Poduslo; M Neal; K Herring; J Shelly
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

2.  Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.

Authors:  Cheng Ma; Jin Li; Zhijun Bao; Qingwei Ruan; Zhuowei Yu
Journal:  Biomed Res Int       Date:  2015-11-23       Impact factor: 3.411

3.  Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease.

Authors:  Francisco Altimiras; Barbara Uszczynska-Ratajczak; Francisco Camara; Anna Vlasova; Emilio Palumbo; Stephen Newhouse; Robert M J Deacon; Leandro A E Farias; Michael J Hurley; David E Loyola; Rodrigo A Vásquez; Richard Dobson; Roderic Guigó; Patricia Cogram
Journal:  Front Aging Neurosci       Date:  2017-03-20       Impact factor: 5.750

4.  Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients.

Authors:  Michal Prendecki; Jolanta Florczak-Wyspianska; Marta Kowalska; Jan Ilkowski; Teresa Grzelak; Katarzyna Bialas; Malgorzata Wiszniewska; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Oncotarget       Date:  2018-10-16

Review 5.  Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.

Authors:  Krzysztof Laudanski
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 6.208

6.  Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation.

Authors:  Eiron Cudaback; Xianwu Li; Yue Yang; Thomas Yoo; Kathleen S Montine; Suzanne Craft; Thomas J Montine; Christopher Dirk Keene
Journal:  J Neuroinflammation       Date:  2012-08-10       Impact factor: 8.322

7.  Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.

Authors:  Qin Zhou; Fan Zhao; Ze-ping Lv; Chen-guang Zheng; Wei-dong Zheng; Liang Sun; Na-na Wang; Shenghang Pang; Fabiana Michelsen de Andrade; Mian Fu; Xiang-hua He; Juan Hui; WenyYu Jiang; Chu-yu Yang; Xiao-hong Shi; Xiao-quan Zhu; Guo-fang Pang; Yi-ge Yang; Hai-qun Xie; Wan-dong Zhang; Cai-you Hu; Ze Yang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

8.  Cloning and characterization of an apolipoprotein C2 promoter in the mouse central nervous system.

Authors:  Zhaoyang Li; Bing Du; Shengyang Li; Xiangchuan Lv; Shenglai Zhou; Yang Yu; Wei Wang; Zhihong Zheng
Journal:  Neural Regen Res       Date:  2013-01-15       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.